LARIMAR THERAPEUTICS INC (LRMR) Stock Analyst Ratings
USA - NASDAQ:LRMR - US5171251003 - Common Stock
3.38 USD
-0.01 (-0.29%)
ChartMill assigns a Buy % Consensus number of 89% to LRMR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.97. This target is 402.05% above the current price.
LRMR was analyzed by 18 analysts. The buy percentage consensus is at 89. So analysts seem to be very confident about LRMR.
In the previous month the buy percentage consensus was at a similar level.
LRMR was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-02 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-09-30 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-09-30 | Baird | Maintains | Outperform -> Outperform |
| 2025-08-19 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-08-15 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-06-25 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-06-24 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-06-24 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-03-25 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-03-25 | Baird | Maintains | Outperform -> Outperform |
| 2025-03-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-29 | Truist Securities | Initiate | Buy |
| 2025-01-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-16 | Oppenheimer | Initiate | Outperform |
| 2024-10-03 | Wedbush | Initiate | Outperform |
| 2024-10-02 | HC Wainwright & Co. | Initiate | Buy |
| 2024-09-12 | Jones Trading | Initiate | Buy |
| 2024-09-04 | Baird | Initiate | Outperform |
| 2024-05-31 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-05-22 | Citigroup | Maintains | Buy -> Buy |
| 2024-05-21 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-04-03 | Leerink Partners | Initiate | Outperform |
| 2024-03-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-03-12 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-02-13 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-02-13 | Citigroup | Maintains | Buy -> Buy |
LARIMAR THERAPEUTICS INC / LRMR FAQ
What is the price target for LRMR stock?
18 analysts have analysed LRMR and the average price target is 16.97 USD. This implies a price increase of 402.04% is expected in the next year compared to the current price of 3.38.
What is the consensus rating for LARIMAR THERAPEUTICS INC (LRMR) stock?
The consensus rating for LARIMAR THERAPEUTICS INC (LRMR) is 88.8889 / 100 . This indicates that analysts generally have a positive outlook on the stock.